Roivant Sciences Ltd
For the period ended Dec 31, 2023. Filed Feb 13, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Dec 31, 2023 · Filed Feb 13, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
| Item 5. | Other Information. |
|---|
On February 9, 2024. the Company’s Board of Directors approved a special one-time cash retention bonus award to Richard Pulik, the Company’s Chief Financial Officer, in the aggregate amount of $2.8 million. Mr. Pulik’s retention bonus will vest and become payable as follows: 50% of the retention bonus will be vested and payable within thirty days of the grant date, (ii) 25% of the retention bonus will vest and become payable on or about September 20, 2024 and the remaining 25% of the retention bonus will vest and become payable on or about September 19, 2025, in each case subject to Mr. Pulik’s continued employment through the applicable vesting date. In the event Mr. Pulik’s employment is terminated without Cause (as defined in the Company’s 2021 Equity Incentive Plan) prior to the final vesting date, Mr. Pulik will be entitled to receive any unvested portion of his retention bonus within sixty days of his termination date, subject to his execution and non-revocation of a release of claims. The above-described terms of Mr. Pulik’s cash retention bonus award are similar to awards previously made to other employees out of the $76.9 million employee Cash Bonus Program approved by the Company’s Board of Directors in December 2023.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.